CAMBRIDGE, MA -- From Tuesday, May 20 to Wednesday, May 21, MIT will host the International Symposium on Continuous Manufacturing of Pharmaceuticals to consider ways to accelerate the adoption of continuous manufacturing by the pharmaceutical industry and discuss how international research groups might better collaborate in support of this effort. The event will bring together academics and regulators with pharmaceutical end users and suppliers.
Organized jointly by MIT and the Continuous Manufacturing and Crystallisation Consortium (CMAC), the symposium stems from a charge by Janet Woodcock, director of the U.S. Food and Drug Administration’s Center for Drug Evaluation Research (CDER), to prioritize making continuous pharmaceutical manufacturing a reality. Woodcock will serve as the keynote speaker on the first day of the symposium.
The event will feature a series of white paper presentations on what the future of pharmaceutical manufacturing could potentially look like from development to supply chains. A full agenda, including access to all white papers, is available here: http://iscmp.mit.edu/
• Janet Woodcock, director, CDER at the FDA
• Prof. Bernhardt Trout, Director, Novartis-MIT Center for Continuous Manufacturing
Tuesday, May 20
9:00 a.m. to 6:30 p.m.
* Please note that Janet Woodcock will speak at 11:00 a.m.
Wednesday, May 21
8:45 a.m. to 4:15 p.m.
Morss Hall (Room 140)
142 Memorial Drive
Cambridge, MA 02142
Reporters interested in attending or speaking with Prof. Trout should email email@example.com.
Reporters interested in speaking with Janet Woodcock should contact Jeff Ventura at Jeff.Ventura@fda.hhs.gov.